血清生物标志物在轻度创伤性脑损伤诊断与分层中的应用价值
该研究在7个急诊科纳入247例18至80岁钝性闭合性头部外伤成人,伤后4小时内行头部CT、6小时内采血检测GFAP、S-100β和UCH-L1。188例符合轻度创伤性脑损伤标准,其中34例(18.1%)CT有急性异常(复杂型)。三种标志物均能显著区分轻度创伤性脑损伤与无轻度创伤性脑损伤(AUC:GFAP 0.70、S-100β 0.69、UCH-L1 0.65,p=0.17),S-100β敏感性最高(96.5%),GFAP阳性预测值最高(96.5%),但阴性预测值仅31%至35%,不能可靠排除脑震荡。
要点
- 伤后6小时内单次血清GFAP、S-100β、UCH-L1均可显著区分轻度创伤性脑损伤与无轻度创伤性脑损伤,AUC分别为0.70、0.69、0.65(p=0.17)。
- S-100β对轻度创伤性脑损伤敏感性最高(96.5%),GFAP阳性预测值最高(96.5%),但三者阴性预测值仅31%至35%,不能可靠排除脑震荡。
- GFAP阳性与脑震荡存在相关,阳性似然比8.7,阴性似然比0.59。
- 188例轻度创伤性脑损伤中34例(18.1%)CT有急性异常(复杂型),复杂型标志物浓度最高、无轻度创伤性脑损伤组最低(p<0.0001)。
适用人群与场景
- 18至80岁、因钝性闭合性头部外伤就诊于7个急诊科的成人。
- 需在伤后4小时内行头部CT、伤后6小时内采血检测生物标志物。
诊断标准与关键阈值
- 轻度创伤性脑损伤:初始GCS>13,且满足以下之一:意识丧失、创伤后遗忘或意识模糊。
- 复杂型轻度创伤性脑损伤:符合轻度创伤性脑损伤且头部CT有急性异常。
- 无并发症轻度创伤性脑损伤:符合轻度创伤性脑损伤且头部CT正常。
- 无轻度创伤性脑损伤:GCS=15、无意识丧失、无创伤后遗忘且无意识模糊。
研究设计与关键结果
- 研究类型为在7个急诊科开展的前瞻性观察性研究,共纳入247例,188例符合轻度创伤性脑损伤标准,其中34例(18.1%)CT有急性异常(复杂型)。
- 研究人群平均年龄45.8(±17.3)岁,59.9%为男性。
- 各组间所有生物标志物中位血清浓度均显著不同,无轻度创伤性脑损伤组最低,无并发症和复杂型轻度创伤性脑损伤组依次升高(p<0.0001)。
- 三种标志物区分轻度创伤性脑损伤与无轻度创伤性脑损伤的AUC:GFAP 0.70、S-100β 0.69、UCH-L1 0.65(p=0.17)。
- 轻度创伤性脑损伤敏感性S-100β最高(96.5%);阴性预测值UCH-L1 31%至GFAP 35%;阳性预测值S-100β 75.5%至GFAP 96.5%。
- 阴性似然比GFAP 0.59至UCH-L1 0.71,阳性似然比UCH-L1和S-100β均为1.0、GFAP为8.7。
证据类型、等级与局限
- 证据类型:在7个急诊科开展的前瞻性观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,伤后6小时内单次血清GFAP、UCH-L1或S-100β可能有助于识别和分层急诊头部外伤患者的脑损伤严重程度。
- 作者认为,上述标志物不能可靠排除脑震荡诊断;GFAP阳性与脑震荡存在相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective was to compare test characteristics of a single serum concentration of glial fibrillary acidic protein (GFAP), S-100β, and ubiquitin carboxyl terminal hydrolase L1 (UCH-L1), obtained within 6 hours of head injury, to diagnose mild traumatic brain injury (mTBI) in head-injured subjects.
METHODS: Adults aged 18 to 80 years who presented to one of seven EDs with a blunt closed head injury underwent head CT within 4 hours of injury and had blood drawn for biomarker analysis within 6 hours of injury were eligible. Subjects were considered to have mTBI if they had an initial Glasgow Coma Scale (GCS) > 13 and met one or more of the following criteria: loss of consciousness (LOC), posttraumatic amnesia, or confusion. Subjects with mTBI and an abnormal head computed tomography (CT) scan were categorized as complicated mTBI; those with a normal head CT were categorized as uncomplicated mTBI; and subjects with a GCS = 15, no LOC, no posttraumatic amnesia, and no confusion were considered to not have a mTBI. Biomarker concentration measurements for GFAP and UCH-L1 were performed using an enzyme-linked immunosorbent assay. S-100β concentration was determined using an electrochemiluminescence immunoassay. Median biomarker concentration for each group was compared using the Kruskal-Wallis test. Logistic regression was used to determine area under the receiver operating curve (AUC) for each of the three biomarkers. Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and negative and positive likelihood ratios (LRs) for the three biomarkers to differentiate between complicated mTBI, uncomplicated mTBI, and no mTBI were calculated.
RESULTS: A total of 247 subjects were enrolled and had adequate clinical and biomarker information for analysis. A total of 188 met criteria for mTBI, with 34 (18.1%) having an acute abnormality on CT (complicated mTBI). The mean (±SD) age of the study population was 45.8 (±17.3) years, and 59.9% were male. Median serum concentrations for all biomarkers were significantly different between groups, lowest in the no mTBI group, and progressively increasing in the uncomplicated and complicated mTBI groups (p < 0.0001). All three biomarkers were significant classifiers of mTBI versus no mTBI, with the following AUCs: GFAP, 0.70; S-100β, 0.69; and UCH-L1, 0.65 (p = 0.17). Sensitivity for mTBI was highest for S-100β (96.5%). NPVs ranged from 31% for UCH-L1 to 35% for GFAP. PPVs ranged from 75.5% for S-100β to 96.5% for GFAP. Negative LR ranged from 0.59 for GFAP to 0.71 for UCH-L1, with positive LR ranging from 1.0 for both UCH-L1 and S-100β to 8.7 for GFAP.
CONCLUSION: A single serum concentration of GFAP, UCH-L1, or S-100β within 6 hours of head injury may be useful in identifying and stratifying the severity of brain injury in emergency department patients with head trauma, but cannot reliably exclude a diagnosis of concussion. A positive GFAP was associated with the presence of concussion.
参考来源
- Lewis LM, Schloemann DT, Papa L, et al. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury. Acad Emerg Med. 2017. PMID: 28170122. doi:10.1111/acem.13174
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。